SCHEMBL8796366

SCHEMBL8796366

CC(C)(C)C(O[SiH](c1ccccc1)c1ccccc1)c1cccc(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.42
TDO2 P48775 1/20 0.42
ALDH1A1 P00352 2/20 0.34
SLC6A9 P48067 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SLC6A2 P23975 4/20 0.32
SLC6A4 P31645 4/20 0.32
SLC18A3 Q16572 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
MAPK1 P28482 1/20 0.31
CYP3A4 P08684 3/20 0.30
CYP2D6 P10635 3/20 0.30
SLC6A3 Q01959 3/20 0.30
MAOB P27338 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5207671 0.83 HTR2A (0.36) ALDH1A1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL6622199 0.82 MAOB (0.34) ALDH1A1MEN1KMT2ASLC6A2SLC6A4
SCHEMBL8149465 0.82 ADRB1 (0.41) CYP3A4SLC6A3
SCHEMBL7310726 0.81 IDO1 (0.39) IDO1TDO2ALDH1A1SLC6A2SLC6A4
SCHEMBL8795978 0.79 TRPA1 (0.32)
SCHEMBL8796135 0.79 TSHR (0.34) MEN1KMT2ASLC6A2SLC6A4SLC6A3
SCHEMBL6132657 0.77 KDM4E (0.31) MEN1KMT2ACYP3A4CYP2D6
SCHEMBL6619259 0.77 ACP3 (0.45) ALDH1A1MEN1KMT2ACYP2D6
SCHEMBL153891 0.76 PTGFR (0.32) CYP3A4
SCHEMBL8794946 0.76 ENPP2 (0.35) MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0629604-B1 Alicyclic phospholipase A2 inhibitors BRISTOL MYERS SQUIBB CO (US) 1997-04-16 EP disclosed
US-5436369-A Alicyclic phospholipase A2 inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 1995-07-25 US disclosed
EP-0629604-A2 Alicyclic phospholipase A2 inhibitors Bristol-Myers Company (US) 1994-12-21 EP disclosed